Sanjivani paranteral Share Price
Small Cap | Pharmaceuticals and health care | BSE: 531569
₹254.80 2.40 (0.95 %)
Last Updated: 13 Mar 2025 12:00 AM
Overview
Open (₹) 260.90
High (₹) 260.90
Low (₹) 252.60
Prev. Close (₹) 252.40
Volume 4,707
VWAP (₹) 273.72
ROCE (%) 26.41
Industry P/E 43.95
TTM P/E 42.26
P/B Ratio 10.67
Market Cap (₹) Cr.302.75
Dividend Yield (%)--
EPS (₹) 5.28
ROE22.11%
Sales Growth (%) 53.31
Profit Growth (%)36.65
Day Range
260.90260.90
52 Week Range
122.15396.95
Historical Returns
Returns (6M)
-23.33 %
Returns (1Y)
89.37 %
Returns (3Y)
291.1 %
Returns (5Y)
2981.02 %
Returns (6M)
-23.33 %
Returns (1Y)
89.37 %
Returns (3Y)
291.1 %
Returns (5Y)
2981.02 %
SWOT Analysis
No data available
Technicals
Technical Rating
RSI 43.89
MFI 19.71
ATR 18.93
Commodity Channel Index -52.71
ROC125 -9.80
ROC21 -18.04
Williams %R -61.89
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 284.91 | 298.78 | 305.71 | 277.98 | 264.11 | 257.18 | 243.31 |
Week Ago | 275.59 | 278.97 | 285.74 | 268.82 | 265.44 | 258.67 | 255.29 |
Month Ago | 326.74 | 333.12 | 339.24 | 320.62 | 314.24 | 308.12 | 301.74 |
EMA & SMA
254.80
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 279.32
9 Day 272.06
10 Day 275.59
12 Day 280.10
14 Day 282.76
20 Day 298.97
26 Day 306.60
50 Day 330.67
100 Day 314.64
200 Day 277.36
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
MONIKA GARWARE | bulk | Sell | 19 Feb, 2025 | ₹243.44 | 2,27,509 | BSE |
NEXT ORBIT VENTURES FUND | bulk | Sell | 26 Aug, 2024 | ₹290.00 | 2,00,000 | BSE |
NEXT ORBIT VENTURES FUND | bulk | Sell | 22 Aug, 2024 | ₹280.46 | 1,00,000 | BSE |
SUREKHA HARAN | bulk | Sell | 20 Dec, 2023 | ₹152.70 | 1,01,034 | BSE |
SUREKHA HARAN | bulk | Buy | 18 Sept, 2023 | ₹100.05 | 50,000 | BSE |
SETU SECURITIES PVT. LTD. | bulk | Buy | 15 Sept, 2023 | ₹100.06 | 50,000 | BSE |
SUREKHA HARAN | bulk | Buy | 12 Sept, 2023 | ₹100.00 | 50,000 | BSE |
WOODSTOCK SECURITIES PRIV ATE LTD | bulk | Sell | 27 Mar, 2023 | ₹27.02 | 55,966 | BSE |
WOODSTOCK SECURITIES PRIV ATE LTD | bulk | Sell | 24 Mar, 2023 | ₹25.94 | 79,292 | BSE |
NEXT ORBIT VENTURES FUND | bulk | Sell | 20 Mar, 2023 | ₹32.75 | 60,000 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
26 Nov, 2024 | ASHWANI KHEMKA | Acquisition | ₹135.10 | 1,97,394 | BSE |
26 Sept, 2023 | Ashwani Khemka | Acquisition | ₹107.16 | 10,200 | BSE |
22 Sept, 2023 | Ashwani Khemka | Acquisition | ₹106.16 | 10,000 | BSE |
11 Sept, 2023 | Ashwani Khemka | Acquisition | ₹93.14 | 21,300 | BSE |
01 Sept, 2023 | Ashwani Khemka | Acquisition | ₹87.62 | 22,000 | BSE |
28 Jun, 2023 | Ashwani Khemka | Acquisition | ₹65.10 | 5,000 | BSE |
17 Jun, 2023 | Ashwani Khemka | Acquisition | ₹69.10 | 37,500 | BSE |
07 Jun, 2023 | Ashwani Khemka | Acquisition | ₹71.50 | 5,000 | BSE |
02 Jun, 2023 | Ashwani Khemka | Acquisition | ₹62.59 | 32,000 | BSE |
31 May, 2023 | Ashwani Khemka | Acquisition | ₹59.99 | 16,500 | BSE |
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
15 Feb, 2025 | BSE India | Earnings Call Transcript Conducted on 11th February, 2025 |
12 Feb, 2025 | BSE India | As per attached document |
10 Feb, 2025 | BSE India | Investor Presentation for the Quarter ended 31st December, 2024 |
10 Feb, 2025 | BSE India | Press Release for the quarter ended 31st December, 2024 |
10 Feb, 2025 | BSE India | Investor Presentation for the Quarter ended 31st December, 2024 |
10 Feb, 2025 | BSE India | Statement on Deviation or Variation for the Quarter ended 31st December, 2024 |
10 Feb, 2025 | BSE India | Integrated Filing (Financial) for the Quarter ended 31st December, 2024 |
10 Feb, 2025 | BSE India | Un-Audited Financial Results for the Quarter ended 31st December, 2024 |
10 Feb, 2025 | BSE India | In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (\the Listing Regulations\), we wish to inform you that, in their meeting held today i.e. 10th February, 2025 has inter-alia considered and approved the following:\r\n\r\n1. Unaudited Financial Results (Standalone and consolidated) along with Limited Review Report as submitted by the statutory auditor of the Company for the Third Quarter Ended 31st December, 2024. \r\n\r\n |
04 Feb, 2025 | BSE India | Intimation of Investor Meet dated 11th February, 2025 |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 31 Jan, 2025 | 10 Feb, 2025 |
Quarterly Results | -- | 22 Oct, 2024 | 28 Oct, 2024 |
A.G.M. | -- | 05 Sept, 2024 | 09 Sept, 2024 |
Quarterly Results & A.G.M. | -- | 30 Jul, 2024 | 06 Aug, 2024 |
Audited Results | -- | 07 May, 2024 | 13 May, 2024 |
Others | Inter alia, 1. To consider the proposal for Change in Designation of Mr. Srivardhan Ashwani Khemka (DIN: 08942106), from Non-Executive Director to Executive Director with effect from 08th April, 2024; | 03 Apr, 2024 | 08 Apr, 2024 |
Quarterly Results | -- | 30 Jan, 2024 | 05 Feb, 2024 |
Quarterly Results | -- | 12 Oct, 2023 | 18 Oct, 2023 |
Quarterly Results | -- | 20 Jul, 2023 | 24 Jul, 2023 |
Audited Results | -- | 02 May, 2023 | 06 May, 2023 |
Share Holding Pattern
Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Feb, 2024 | Dec, 2023 | Sept, 2023 |
---|
About Sanjivani paranteral
Sanjivani paranteral is a Public Limited Listed company incorporated on 05/10/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24300MH1994PLC081752 and registration number is 081752. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 54.41 Cr. and Equity Capital is Rs. 11.68 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1994
Managing Director
Mr. Ashwani Khemka
NSE Symbol
--
Sanjivani paranteral Management
Name | Designation |
---|---|
Mr. Ashwani Khemka | Chairman & Managing Director |
Mrs. Mrunmai Sarvankar | Ind. Non-Executive Director |
Mr. Srivardhan Khemka | Executive Director |
Mrs. Monika A Singhani | Ind. Non-Executive Director |
Mr. Abhay Shah | Ind. Non-Executive Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45 ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45 ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Sanjivani paranteral
What is the share price of Sanjivani paranteral?
The share price of Sanjivani paranteral on 13 Mar, 2025 is ₹ 254.80.
What is 52W high and 52W low share price of Sanjivani paranteral?
The highest and lowest 52W share prices of Sanjivani paranteral are ₹ 396.950 and ₹ 122.150
What is the market cap of Sanjivani paranteral?
The market capitalization of Sanjivani paranteral as of 13 Mar, 2025 is ₹ 302.75 Crores
What is the P/E ratio of Sanjivani paranteral?
The current P/E ratio of Sanjivani paranteral as of 13 Mar, 2025 is 43.95
What is the PB ratio of Sanjivani paranteral?
The PB ratio of Sanjivani paranteral as of 13 Mar, 2025 is 10.67
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)